Cardiff Lexington Corp (CDIX)
About Cardiff Lexington Corp
CARDIFF LEXINGTN CORP
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $11.5M
- Net income
- -$5.5M
- Total assets
- $29.1M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Cardiff Lexington Corp (CDIX) Stock Price
- Reported a net loss of $5.5M in FY2025.
- Trading 95% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Cardiff Lexington Corp.
Write a review
Cardiff Lexington Corp: frequently asked questions
Is Cardiff Lexington Corp an American company?
Cardiff Lexington Corp is a US-based company headquartered in Las Vegas, Nevada, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Cardiff Lexington Corp headquartered?
Cardiff Lexington Corp is headquartered in Las Vegas, Nevada, United States.
Is Cardiff Lexington Corp publicly traded?
Yes — Cardiff Lexington Corp is a publicly traded company. Its stock trades under the ticker symbol CDIX on the OTC.
What does Cardiff Lexington Corp do?
Cardiff Lexington Corp is an American Medical Devices company in the Health & Beauty sector.
